Hit enter to search or ESC to close

James Kerr

James Kerr has over 25 years of experience in product development in the pharmaceutical industry, with a particular focus on analytical sciences, formulation development, and manufacturing. He was part of multiple approved NDAs and commercial launches.

Prior to joining Alterity, he worked for Teva and Auspex Pharmaceuticals where he was the Executive Director of Chemistry, Manufacturing, and Controls, and oversaw the development and FDA approval of Austedo®, the first approved deuterium-substituted small molecule drug. Prior to Teva, Jim held positions at Pfizer Inc, CovX, Chugai Pharmaceutical Co, Dura Pharmaceuticals, and 3M Pharmaceuticals. 


VP, Chemistry, Manufacturing and Controls